How Trump’s victory will change healthcare consolidation December 05, 2016By Christian AutyWill President-elect Donald Trump affect the outcome of the Anthem-Cigna and Aetna-Humana mergers? How will Trump change healthcare? 6 of the biggest questions answered November 29, 2016By Karen AppoldExperts share how Trump could change Obamacare coverage, accessibility, affordability, Medicare/Medicaid, price transparency, and more. Top 3 healthcare policy changes Trump’s victory could bring November 21, 2016By Bob MorganFollowing the GOP’s success on Election Day, the nation is quickly tuning in to what this all means for healthcare coverage. What Trump’s victory means for healthcare: Industry leaders sound off November 10, 2016By Aubrey WestgateHealthcare industry leaders and policy analysts discuss how the election results could impact healthcare. Managed Healthcare Executive Politics and Policy Survey 2016 October 17, 2016By Aubrey WestgateWith the presidential election quickly approaching, here’s your chance to know where your peers stand on key issues. Three healthcare questions to consider as election 2016 approaches October 08, 2016By Don Hall MPHIt’s time to step back and assess how the election could impact the managed care industry. Medicaid Final Rule: Three top line issues to watch October 07, 2016By Mara Baer MPHIn April CMS released final rules outlining significant updates to the Medicaid managed care program. Here are the top issues to watch. DOJ’s merger complaints: An attorney’s 4 takeaways August 08, 2016By Christian AutyBelow are some perspectives on what these complaints mean for the parties’ chances and for consolidation in healthcare more generally. Presidential election: 4 things managed care should watch July 30, 2016By Karen AppoldAs the 2016 presidential election approaches, analysts and experts are advising healthcare executives to watch and monitor certain issues. Payer mega mergers in question: Industry expert weighs in July 27, 2016By Aubrey WestgateMichael Abrams of Numerof and Associates healthcare consulting firm discusses how the DOJ’s actions to block the Anthem-Cigna and Aetna-Humana mergers could affect the industry.